Cargando…

Silencing alanine transaminase 2 in diabetic liver attenuates hyperglycemia by reducing gluconeogenesis from amino acids

Mostrar otras versiones (1)

Hepatic gluconeogenesis from amino acids contributes significantly to diabetic hyperglycemia, but the molecular mechanisms involved are incompletely understood. Alanine transaminases (ALT1 and ALT2) catalyze the interconversion of alanine and pyruvate, which is required for gluconeogenesis from alan...

Descripción completa

Detalles Bibliográficos
Autores principales:	Martino, Michael R., Gutiérrez-Aguilar, Manuel, Yiew, Nicole K.H., Lutkewitte, Andrew J., Singer, Jason M., McCommis, Kyle S., Ferguson, Daniel, Liss, Kim H.H., Yoshino, Jun, Renkemeyer, M. Katie, Smith, Gordon I., Cho, Kevin, Fletcher, Justin A., Klein, Samuel, Patti, Gary J., Burgess, Shawn C., Finck, Brian N.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9121396/ https://www.ncbi.nlm.nih.gov/pubmed/35476997 http://dx.doi.org/10.1016/j.celrep.2022.110733

Ejemplares similares

Silencing alanine transaminase 2 in diabetic liver attenuates hyperglycemia by reducing gluconeogenesis from amino acids
por: Martino, Michael R., et al.
Publicado: (2022)

Effects of hepatic mitochondrial pyruvate carrier deficiency on de novo lipogenesis and gluconeogenesis in mice
por: Yiew, Nicole K.H., et al.
Publicado: (2023)

Effects of hepatic mitochondrial pyruvate carrier deficiency on de novo lipogenesis and glycerol-mediated gluconeogenesis in mice
por: Yiew, Nicole K.H., et al.
Publicado: (2023)

Mitochondrial pyruvate carrier inhibition initiates metabolic crosstalk to stimulate branched chain amino acid catabolism
por: Ferguson, Daniel, et al.
Publicado: (2023)

Hepatic pyruvate and alanine metabolism are critical and complementary for maintenance of antioxidant capacity and resistance to oxidative insult
por: Yiew, Nicole K.H., et al.
Publicado: (2023)

Treating Hepatic Steatosis and Fibrosis by Modulating Mitochondrial Pyruvate Metabolism
por: McCommis, Kyle S., et al.
Publicado: (2018)

The Hepatic Mitochondrial Pyruvate Carrier as a Regulator of Systemic Metabolism and a Therapeutic Target for Treating Metabolic Disease
por: McCommis, Kyle S., et al.
Publicado: (2023)

A Rise in Aspartate Transaminase and Alanine Transaminase Associated With Ondansetron Administration in a Pregnant Female
por: Couse, Michael, et al.
Publicado: (2020)

Treating fatty liver disease by modulating mitochondrial pyruvate metabolism
por: Colca, Jerry R., et al.
Publicado: (2017)

The association of aspartate transaminase-to-alanine transaminase ratio and metabolic syndrome among HIV patients in Sidama Region, South Ethiopia
por: Abera, Wondwossen, et al.
Publicado: (2023)

Occult Hepatitis B Virus Among the Patients With Abnormal Alanine Transaminase
por: Makvandi, Manoochehr, et al.
Publicado: (2014)

Evolutionary Diversification of Alanine Transaminases in Yeast: Catabolic Specialization and Biosynthetic Redundancy
por: Escalera-Fanjul, Ximena, et al.
Publicado: (2017)

The Effect of Elevated Alanine Transaminase on Non-invasive Prenatal Screening Failures
por: Chen, Ping, et al.
Publicado: (2022)

Alanine Represses γ-Aminobutyric Acid Utilization and Induces Alanine Transaminase Required for Mitochondrial Function in Saccharomyces cerevisiae
por: Márquez, Dariel, et al.
Publicado: (2021)

Prognostic Value of Aspartate Transaminase/Alanine Transaminase Ratio in Patients With Hepatitis B Virus-Related Hepatocellular Carcinoma Undergoing Hepatectomy
por: Mo, Qiuyan, et al.
Publicado: (2022)

Renal gluconeogenesis in insulin resistance: A culprit for hyperglycemia in diabetes
por: Sharma, Rajni, et al.
Publicado: (2021)

Multiple drugs: Elevated alanine transaminase and off label use: case report
Publicado: (2020)

Metabolic importance of adipose tissue monoacylglycerol acyltransferase 1 in mice and humans
por: Liss, Kim H. H., et al.
Publicado: (2018)

Prognostic value of aspartate transaminase to alanine transaminase (De Ritis) ratio in solid tumors: a pooled analysis of 9,400 patients
por: Wu, Jiayuan, et al.
Publicado: (2019)

Editorial: Diabetes and non-alcoholic fatty liver disease: points of physiological and mechanistic intersection and current co-therapeutic approaches
por: Giannoukakis, Nick, et al.
Publicado: (2023)

COVID-19-related hyperglycemia is associated with infection of hepatocytes and stimulation of gluconeogenesis
por: Barreto, Ester A., et al.
Publicado: (2023)

Prognostic Role of Pretreatment De Ritis Ratio (Aspartate Transaminase/Alanine Transaminase Ratio) in Urological Cancers: A Systematic Review and Meta-Analysis
por: Su, Shiqiang, et al.
Publicado: (2020)

Clinical Significance of Pre-to-Postoperative Dynamics of Aspartate Transaminase/Alanine Transaminase Ratio in Predicting the Prognosis of Renal Cell Carcinoma after Surgical Treatment
por: Kang, Minyong, et al.
Publicado: (2020)

Elevated levels of alanine transaminase and triglycerides within normal limits are associated with fatty liver
por: TOMIZAWA, MINORU, et al.
Publicado: (2014)

Fusion of Formate Dehydrogenase and Alanine Dehydrogenase as an Amino Donor Regenerating System Coupled to Transaminases
por: Marchini, Valentina, et al.
Publicado: (2022)

A Sweet New Role for Ubiquitin-Specific Protease 2 in Controlling Hepatic Gluconeogenesis
por: Finck, Brian N.
Publicado: (2012)

Prognostic Values of Fluctuations in Serum Levels of Alanine Transaminase in Inactive Carrier State of HBV Infection
por: Farzi, Hossein, et al.
Publicado: (2014)

The Association between Fruit and Vegetable Intake and Liver Enzymes (Aspartate and Alanine Transaminases) in Tehran, Iran
por: Mollahosseini, Mehdi, et al.
Publicado: (2017)

Mesenteric Panniculitis with Raised Alanine Transaminase Levels: A Rare Case Report from Pakistan
por: Mahmood, Samar, et al.
Publicado: (2019)

Preoperative aspartate transaminase/alanine transaminase ratio as a prognostic biomarker in primary non-muscle-invasive bladder cancer: a propensity score-matched study
por: Cheng, Xiaofeng, et al.
Publicado: (2021)

Exogenous d‐β‐hydroxybutyrate lowers blood glucose in part by decreasing the availability of L‐alanine for gluconeogenesis
por: Soto‐Mota, Adrian, et al.
Publicado: (2021)

E2F1 promotes hepatic gluconeogenesis and contributes to hyperglycemia during diabetes
por: Giralt, Albert, et al.
Publicado: (2018)

An ancestral role for the mitochondrial pyruvate carrier in glucose-stimulated insulin secretion
por: McCommis, Kyle S., et al.
Publicado: (2016)

Identification of Novel Mitochondrial Pyruvate Carrier Inhibitors by Homology Modeling and Pharmacophore-Based Virtual Screening
por: Hegazy, Lamees, et al.
Publicado: (2022)

Comparison of Therapeutic Response and Clinical Outcome between HCV Patients with Normal and Abnormal Alanine Transaminase Levels
por: Wu, Cheng-Kung, et al.
Publicado: (2016)

The effectiveness of fermented turmeric powder in subjects with elevated alanine transaminase levels: a randomised controlled study
por: Kim, Sang-Wook, et al.
Publicado: (2013)

Influence of Alanine Transaminase Levels on Alpha-Fetoprotein for Predicting Hepatocellular Carcinoma in Patients with Hepatitis B Infection
por: Chen, Jiahao, et al.
Publicado: (2020)

Characterization of T cell immunity in chronic hepatitis B virus-infected mothers with postpartum alanine transaminase flare
por: Huang, Meiting, et al.
Publicado: (2021)

Baseline aspartate aminotransferase/alanine transaminase ratio is associated with 3-year mortality in peritoneal dialysis patients
por: Liao, Ruoxi, et al.
Publicado: (2022)

Undiagnosed abnormal alanine transaminase levels in vulnerable populations: Impact of sex, race/ethnicity, and body mass
por: Kim, Rebecca G., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_1jbrujkvpojnb1krcqplnahu7m